Skip to main content
Betta Pharmaceuticals Co.,Ltd logo

Betta Pharmaceuticals Co.,Ltd — Investor Relations & Filings

Ticker · 300558 ISIN · CNE100002DD9 LEI · 8368009YF4Y6NC7HVB09 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,656 across all filing types
Latest filing 2019-10-24 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300558

About Betta Pharmaceuticals Co.,Ltd

https://www.bettapharma.com

Betta Pharmaceuticals Co.,Ltd. focuses on the research, development, and commercialization of innovative oncology medications. The organization specializes in targeted therapies, particularly for the treatment of lung cancer and other solid tumors. Its portfolio includes Icotinib, a small-molecule EGFR tyrosine kinase inhibitor, and Ensartinib, an ALK inhibitor designed for non-small cell lung cancer. The company operates a comprehensive R&D infrastructure dedicated to molecular biology, medicinal chemistry, and clinical development. By prioritizing precision medicine, the firm aims to deliver high-quality therapeutic solutions that address complex oncological challenges. Its pipeline encompasses a diverse range of candidates, including small molecules and biologics, aimed at improving patient outcomes through advanced scientific innovation.

Recent filings

Filing Released Lang Actions
第二届董事会第三十五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the 35th meeting of the 2nd Board of Directors of Betta Pharmaceuticals Co., Ltd. It details the meeting's convening, attendance, and the approval of the 2019 Q3 report and accounting policy changes. The document references that the full 2019 Q3 report is disclosed elsewhere on a public information website, indicating this document itself is not the full quarterly report but a board meeting resolution announcement. The content focuses on board decisions and meeting procedures, which aligns with Board/Management Information filings. The document length is short (1261 characters), and it is not a full financial report but a meeting resolution announcement. Therefore, the appropriate classification is Board/Management Information (MANG).
2019-10-24 Chinese
2019年第三季度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (470 characters) indicating that the company's 2019 third quarter report has been approved and is available on a regulatory website. It does not contain the actual financial data or the full report itself, but rather informs investors where to find the full quarterly report. According to the 'MENU VS MEAL' rule, such a brief notice that a report is published elsewhere is classified as a Report Publication Announcement (RPA).
2019-10-24 Chinese
2019年第三季度报告全文
Interim / Quarterly Report Classification · 100% confidence The document is titled "2019 年第三季度报告全文" which translates to "2019 Third Quarter Report Full Text." It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and explanations of financial metrics and changes compared to prior periods. The document covers a period shorter than a full fiscal year (the third quarter of 2019). It includes substantive financial data and analysis, not just an announcement or summary. The presence of detailed financial statements and management discussion of financial results confirms this is an Interim / Quarterly Report. Therefore, the appropriate classification is 'IR'. 9M 2019
2019-10-24 Chinese
关于公司董事会换届选举的提示性公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement regarding the election and nomination process for the company's board of directors. It includes information about the composition of the new board, nomination procedures, qualifications for directors, and required documentation for nominees. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management changes and election procedures, which aligns with announcements about changes in the company's board of directors. Therefore, the document fits the category of Board/Management Information (MANG). The document length and detail confirm it is not a brief announcement or a report publication notice.
2019-10-23 Chinese
关于公司监事会换届选举的提示性公告
Board/Management Information Classification · 95% confidence The document is a formal announcement from a company regarding the upcoming election and nomination process for the supervisory board (监事会) members. It details the composition of the new supervisory board, the nomination procedures, qualifications required for candidates, and the timeline for submissions. There is no financial data, earnings information, or detailed report content. The document is not a full annual or interim report, nor is it a call transcript or earnings release. It is also not a voting result announcement but rather a notice about the supervisory board election process. This fits best under Board/Management Information (MANG), as it concerns changes and procedures related to the company's supervisory board members.
2019-10-23 Chinese
2019年前三季度业绩预告
Earnings Release Classification · 95% confidence The document is a performance forecast for the first three quarters of 2019, providing estimated net profit figures and explanations for the changes. It explicitly states that the forecast is unaudited and that detailed financial data will be disclosed in the upcoming third quarter report. The document is short (1268 characters) and serves as a preliminary earnings forecast rather than a full financial report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly or periodical financial results with key highlights only. 9M 2019
2019-10-14 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.